2005
DOI: 10.1016/j.ejrad.2005.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Role of MRI for the diagnosis and prognosis of multiple myeloma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
70
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 176 publications
(72 citation statements)
references
References 30 publications
1
70
0
1
Order By: Relevance
“…However, even in stage I disease (Durie and Salmon) and negative X-ray films bone marrow infiltration in MRI may be detected in 29–50% of patients. Those patients typically show an earlier disease progression [84]. IMWG consensus considered MRI to be the gold-standard imaging technique for detection of bone morrow involvement [85].…”
Section: Monitoring Of Response Toolsmentioning
confidence: 99%
“…However, even in stage I disease (Durie and Salmon) and negative X-ray films bone marrow infiltration in MRI may be detected in 29–50% of patients. Those patients typically show an earlier disease progression [84]. IMWG consensus considered MRI to be the gold-standard imaging technique for detection of bone morrow involvement [85].…”
Section: Monitoring Of Response Toolsmentioning
confidence: 99%
“…Whole-body MR (WBMR) has emerged as the most sensitive imaging modality to date at detecting diffuse and focal multiple myeloma in the spine, as well as the extra-axial skeleton [1921]. Due to its ability to visualise large volumes of bone marrow without inducing radiation exposure and in an acceptable amount of time, MR imaging has become a favoured imaging method for evaluating disease within the bone marrow (Figure 6).…”
Section: Imaging Techniquesmentioning
confidence: 99%
“…A complete response to treatment may be evidenced by complete resolution of the preceding marrow abnormality, and a partial response demonstrated by conversion of a diffuse to a variegated or focal pattern [22]. A good response to treatment may also be evidenced by a reduction in signal intensity on T2-weighted spin echo images and the absence of contrast-induced rim enhancement that was previously present [19]. …”
Section: Imaging Of Response To Treatment and Disease Progressionmentioning
confidence: 99%
“…The morphologic changes indicative of response include reduction in focal lesion size, return from a focal or diffuse pattern of neoplastic marrow involvement to a normal bone marrow appearance, decrease in diffuse marrow enhancement, and in focal lesion enhancement after contrast injection, with sometimes a residual peripheral enhancement halo (Moulopoulos et al 1994). The lack of enhancement within a treated lesion should be considered carefully, as residual viable myeloma cells may be observed in this setting (Baur-Melnyk et al 2005;Lecouvet et al 1998a;Lecouvet et al 2001). The complete disappearance of focal lesions with return to a completely normal marrow signal may be a very slow process (Hanrahan et al 2010).…”
Section: Multiple Myelomamentioning
confidence: 96%
“…This radiographic survey has a limited value for disease follow-up, as the comparison with MRI clearly demonstrates the frequent persisting visibility of lytic areas on radiographs despite evident signs of response based on the bone marrow signal changes at MRI (Baur-Melnyk et al 2005;Moulopoulos et al 1994).…”
Section: Radiographymentioning
confidence: 98%